November 2013 Issue Table Of Contents

From The Editor

• Eli Lilly Research Lab Tour Reveals More Than Meets The Eye

Ask The Board

• Ask The Board November 2013

Capitol Perspectives

• The Disastrous Launch Of Obamacare

Companies To Watch

• Vivaldi Biosciences Approach To Developing A Superior Influenza Vaccine

Outsourcing Insights

• Outsourcing To CROs And CMOs In Emerging Markets In 2014

Bio Innovation notes

• Innovation In Stainless-Steel Bioprocessing

Feature

• From Obscurity To Innovation Engine – The Evolution Of Specialty Pharma
• How To Take Charge Of Your Public-Private Partnerships
• NeoStem’s CEO Spearheads Stem Cell Research Collaboration With The Roman Catholic Church
• Competing In The Rare Disease Space

Inside The Industry

• Financial Metrics For Anti-counterfeiting Programs
• Crowdfunding And The Life Sciences: Will It Work?
• Digging For Big Data Gold: Data Mining As A Route To Drug Development Success
• Guidelines For Launching A Successful Biotech Company

Industry Leader

• How To Apply QbD Principles In Clinical Trials
• What Drives Innovation In Today’s Biopharma Industry?
• Preventing Culture Clash In The Changing Healthcare Landscape